Sumitomo acquires Nufarm for $1.19bn

By Naomi Neilson|08 October 2019

Norton Rose Fulbright has advised Sumitomo on the $1.19 billion purchase of Nufarm.

Firm: Norton Rose Fulbright (Sumitomo Chemical Company Limited)

Deal: Norton Rose Fulbright (NRF) has advised Sumitomo Chemical Company Limited on its agreement to purchase Nufarm Limited’s crop protection business.

Value: $1.19 billion.

Area: M&A.

Key players: The deal was led by partner and head of NRF’s Japan Desk in London Chris Viner and M&A partner Adam Edelman. Silvia Fazio, partner in the NRF Sao Paolo office, coordinated due diligence in South America while George Gibson, head of Tokyo, provided local support.

Special counsel Simon Meagher and senior associate Andrew Clarke also assisted.

Advertisement
Advertisement

Deal significance: A cross-border team from NRF advised Sumitomo on the purchase of Nufarm’s crop protection business in Brazil, Argentina, Columbia and Chile. The deal is valued at $1.19 billion and includes a two-year supply agreement and a transitional service agreement.

Sumitomo was attracted to Nufarm’s strong distribution network in South America and expected the agreement to provide additional value to shareholders. The deal requires shareholder and regulatory approvals before it is completed.

Mr Viner said: “This was a great opportunity to work ‘hand in glove’ with Sumitomo Chemical’s legal team in Tokyo. It was terrific to pull such a complex deal together with our colleagues in Sumitomo in the short timescale demanded by the stock exchange sensitives for both groups.

“The international team spanned the time zones through Australia, Japan, Europe to South America; it was great to see previous deal cooperation between the teams paying dividends.”

This email address is being protected from spambots. You need JavaScript enabled to view it.

Sumitomo acquires Nufarm for $1.19bn
Intro image
lawyersweekly logo
Big Law

latest

When and why will in-house teams choose NewLaw firms?

What advocacy for women in sport has taught Mary Konstantopoulos about her in-house work

‘As a leader, I should be setting an example’: Q&A with Nicole Birman

You’re never going to finish your to-do list, so stop sacrificing your health for it